Two stocks in Medical Instruments & Supplies
EssilorLuxottica vs Gerresheimer: profit, growth, debt and price compared
EssilorLuxottica is stronger on 4 of 6 figures: profit margin, sales growth, debt and analysts' view. Gerresheimer is stronger on 2: price for its expected profit and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| EssilorLuxotticaEL.PA | GerresheimerGXI.DE | |
|---|---|---|
| Net margin | Stronger: 8.5% | −17.5% |
| Revenue growth, past year | Stronger: +5.70% | −0.80% |
| Debt to equity | Stronger: 38.4% | 236.7% |
| Forward P/E | 22.9× | Stronger: 13.5× |
| Dividend yield | 2.17% | — |
| Analysts | Stronger: Buy · 23 | Hold · 12 |
| From its 200-day average | −1.2% | Stronger: +13.7% |
Share price over the past year
- EssilorLuxottica−40.9%
- Gerresheimer+40.9%
21 Nov 202518 Nov 2026
EssilorLuxottica or Gerresheimer: which is stronger?
- EL.PA
Which is more profitable?
EssilorLuxottica keeps more of each sale as profit: 8.5% against −17.5%.
- EL.PA
Which is growing its sales faster?
EssilorLuxottica is growing its sales faster: +5.70% over the past year, against −0.80%.
- EL.PA
Which has borrowed less?
EssilorLuxottica has borrowed less: its debt is 38.4% of what its shareholders own, against 236.7% for Gerresheimer.
- GXI.DE
Which costs less for the profit it is expected to make?
Gerresheimer costs less for the profit it is expected to make: 13.5× its forward earnings, against 22.9×.
Which pays more in dividends?
EssilorLuxottica pays 2.17% a year in dividends for what a share costs, where Gerresheimer pays none.
- EL.PA
Which do analysts rate higher?
Analysts are warmer on EssilorLuxottica: Buy, against Hold for Gerresheimer.
- GXI.DE
Which is in the stronger price trend?
Gerresheimer's price is in the stronger trend: 13.7% above its 200-day average, against 1.2% below.
What each company does
EL.PAEssilorLuxottica
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific.
Reports results on 11 February 2027
GXI.DEGerresheimer
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally.
Reports results on 25 November 2026
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.